A survey of infectious agents as risk factors for primary sclerosing cholangitis: are Chlamydia species involved?
- 1 June 2002
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 14 (6) , 641-648
Abstract
Objectives The aetiology of primary sclerosing cholangitis (PSC) is unknown, and the role of micro-organisms has been studied only to a limited extent. We tested the hypothesis that past or persisting infection with common viruses or atypical bacteria might play a role in genetically susceptible hosts. Design Case–control study. Methods Serological screening for antibodies against 22 viruses as well as Chlamydia spp. and Mycoplasma pneumoniae was carried out in 41 well-established PSC patients. All 5110 sera tested in 1997 for these micro-organisms at our laboratory served as a background reference group. Subsequently, Chlamydia anti-lipopolysaccharide (LPS) antibodies were determined by enzyme-linked immunosorbent assay (ELISA) in the PSC group and in three race-matched control groups (inflammatory bowel disease (IBD) group, n = 35; non-IBD patients group, n = 39; healthy blood donor group, n = 40). Subtyping in Chlamydia trachomatis and C. pneumoniae serotypes by specific anti-major outer membrane protein (MOMP) assays was carried out in the four groups. Immunohistochemical staining using specific markers for chlamydiae was carried out on liver biopsies of 14 PSC patients. Results There was a markedly elevated seroprevalence of Chlamydia-LPS antibodies compared with the 1997 reference group. The odds ratios (ORs) for the presence of immunoglobulin G, immunoglobulin M and immunoglobulin A antibodies for the PSC patients versus the control group were 2.4 (95% confidence interval (CI) 1.1 to 5.4), 1.9 (95% CI 0.9 to 4.0) and 6.7 (95% CI 3.0 to 17.0), respectively. All other micro-organisms tested showed normal antibody profiles that did not differ from the 1997 reference group. The seroprevalence of Chlamydia-anti-LPS antibodies was elevated markedly in the PSC patients compared with the IBD, non-IBD and blood donor groups. The outcomes in the C. trachomatis and C. pneumoniae anti-MOMP assays did not correlate with the anti-LPS-positive PSC sera. The actual presence of Chlamydia bodies in liver tissue could not be demonstrated. Conclusion Our findings suggest an association between PSC and (previous) infection with Chlamydia.Keywords
This publication has 20 references indexed in Scilit:
- Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis.Gut, 1996
- Natural history and prognostic variables in primary sclerosing cholangitisGastroenterology, 1991
- Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysisHepatology, 1989
- Biliary Atresia and Reovirus Type 3 InfectionNew England Journal of Medicine, 1982
- Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitisHepatology, 1981
- Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery.Gut, 1980
- EFFECT OF LONG‐TERM TETRACYCLINE THERAPY, STEROID THERAPY AND COLECTOMY IN PERICHOLANGITIS ASSOCIATED WITH ULCERATIVE COLITISAustralasian Annals of Medicine, 1965
- Experimental Chronic Portal Vein Bacteremia.Experimental Biology and Medicine, 1964
- THE LIVER IN ULCERATIVE COLITIS TREATMENT OF PERICHOLANGITIS WITH TETRACYCLINEThe Lancet, 1959
- THE LIVER IN ULCERATIVE COLITIS THE SIGNIFICANCE OF RAISED SERUM-ALKALINE-PHOSPHATASE LEVELSThe Lancet, 1959